000 | 01978 a2200541 4500 | ||
---|---|---|---|
005 | 20250517182420.0 | ||
264 | 0 | _c20190130 | |
008 | 201901s 0 0 eng d | ||
022 | _a1096-0929 | ||
024 | 7 |
_a10.1093/toxsci/kfx222 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMosedale, Merrie | |
245 | 0 | 0 |
_aTransient Changes in Hepatic Physiology That Alter Bilirubin and Bile Acid Transport May Explain Elevations in Liver Chemistries Observed in Clinical Trials of GGF2 (Cimaglermin Alfa). _h[electronic resource] |
260 |
_bToxicological sciences : an official journal of the Society of Toxicology _c02 2018 |
||
300 |
_a401-411 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aBile Acids and Salts _xblood |
650 | 0 | 4 |
_aBile Ducts _xdrug effects |
650 | 0 | 4 |
_aBilirubin _xblood |
650 | 0 | 4 | _aBiological Transport |
650 | 0 | 4 |
_aCell Survival _xdrug effects |
650 | 0 | 4 | _aClinical Trials, Phase I as Topic |
650 | 0 | 4 |
_aCytochrome P-450 CYP3A _xgenetics |
650 | 0 | 4 | _aHep G2 Cells |
650 | 0 | 4 |
_aHepatocytes _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLiver _xdrug effects |
650 | 0 | 4 | _aMacaca fascicularis |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aNeuregulin-1 _xadverse effects |
650 | 0 | 4 | _aPrimary Cell Culture |
650 | 0 | 4 | _aToxicogenetics |
650 | 0 | 4 |
_aTranscriptome _xdrug effects |
700 | 1 | _aButton, Donald | |
700 | 1 | _aJackson, Jonathan P | |
700 | 1 | _aFreeman, Kimberly M | |
700 | 1 | _aBrouwer, Kenneth R | |
700 | 1 | _aCaggiano, Anthony O | |
700 | 1 | _aEisen, Andrew | |
700 | 1 | _aIaci, Jennifer F | |
700 | 1 | _aParry, Tom J | |
700 | 1 | _aStanulis, Ric | |
700 | 1 | _aSrinivas, Maya | |
700 | 1 | _aWatkins, Paul B | |
773 | 0 |
_tToxicological sciences : an official journal of the Society of Toxicology _gvol. 161 _gno. 2 _gp. 401-411 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1093/toxsci/kfx222 _zAvailable from publisher's website |
999 |
_c27721614 _d27721614 |